New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
https://www.sciencedirect.com/science/article/pii/S2211034821005885
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
https://www.sciencedirect.com/science/article/pii/S2211034821005885